9:02 AM ET
8-K
Business Update
Kala BIO Business Update
KALA BIO announced preliminary unaudited financial results for the third quarter of 2026, reporting a significantly reduced net loss of $0.8 million compared to $7.6 million in the prior year. The company ended the period with $7.0 million in cash and no debt as it continues its strategic shift toward building an AI infrastructure platform for the biotechnology industry.